New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years

doi:10.3748/wjg.v27.i29.4818

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7194)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

414

WORD

135

HTML

3478

Figures (1-1)

267

Tables (1-1)

277

Sum=4571

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

296

Download

752

Sum=1048

Publishing Process of This Article

Item

Count

Browse

473

Download

1102

Sum=1575

Aug 7, 2021 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 7, 2021; 27(29): 4818-4830
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4818

Table 1 Classification of direct-acting antiviral agents[29]

Class	Drug name	HCV genotype
NS3/4A inhibitor	Boceprevir¹	Genotypes 1a and 1b
	Telaprevir¹
	Simeprevir
	Asunaprevir
	Paritaprevir
	Grazoprevir
	Glecaprevir
	Voxilaprevir
NS5A inhibitor	Daclatasvir	All HCV genotypes
	Ledipasvir
	Ombitasvir
	Elbasvir
	Velpatasvir
	Pibrentasvir
NS5B polymerase inhibitor: Nucleoside analogs	Sofosbuvir	All HCV genotypes
NS5B polymerase inhibitor: Non-nucleoside analogs	Dasabuvir	Genotypes 1a and 1b

¹First generation direct-acting antiviral agents.

HCV: Hepatitis C virus.

Citation: Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830
URL: https://www.wjgnet.com/1007-9327/full/v27/i29/4818.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i29.4818